PCM
HAE icon

Prelude Capital Management’s Haemonetics HAE Stock Holding History

Prelude Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,935
Closed -$336K – 1336
2024
Q1 		$336K Buy
3,935
+743
+23% +$58.3K 0.02% 841
2023
Q4 		$273K Sell
3,192
-1,450
-31% -$125K 0.02% 778
2023
Q3 		$416K Buy
+4,642
New +$414K 0.03% 534
2022
Q2 		– Sell
-8,857
Closed -$560K – 1910
2022
Q1 		$560K Buy
+8,857
New +$482K 0.02% 816
2021
Q4 		– Sell
-13,352
Closed -$943K – 2096
2021
Q3 		$943K Sell
13,352
-2,341
-15% -$148K 0.02% 598
2021
Q2 		$1.05M Sell
15,693
-7,204
-31% -$510K 0.03% 590
2021
Q1 		$2.54M Buy
22,897
+5,569
+32% +$689K 0.07% 266
2020
Q4 		$2.06M Buy
17,328
+12,091
+231% +$1.3M 0.05% 288
2020
Q3 		$457K Buy
5,237
+506
+11% +$44.2K 0.02% 459
2020
Q2 		$424K Buy
+4,731
New +$478K 0.02% 512
2020
Q1 		– Sell
-111
Closed -$13K – 1657
2019
Q4 		$13K Buy
+111
New +$13.4K ﹤0.01% 1664
2016
Q3 		– Sell
-4,362
Closed -$126K – 1677
2016
Q2 		$126K Buy
+4,362
New +$132K 0.02% 666
2015
Q2 		– Sell
-1,605
Closed -$72K – 1826
2015
Q1 		$72K Buy
+1,605
New +$67.1K 0.01% 1151

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prelude Capital Management's HAE Position: Q2 2024 in Review

Prelude Capital Management sold out of Haemonetics (HAE) in Q2 2024, closing a stake of 3,935 shares — an estimated $336K sold.

Prelude Capital Management first reported a position in HAE in Q1 2015 and held it in 13 quarters. The position peaked at $2.54M in Q1 2021. 317 funds tracked by Wall St. Rank hold HAE as of Q2 2024.

  • Prelude Capital Management reported no remaining Haemonetics position as of Q2 2024 after selling out during the quarter.
  • Prelude Capital Management sold 3,935 Haemonetics shares in Q2 2024, an estimated $336K.
  • Prelude Capital Management first reported a position in Haemonetics in Q1 2015 and held it in 13 quarters.
  • Prelude Capital Management's Haemonetics position peaked at $2.54M in Q1 2021.
  • 317 funds tracked by Wall St. Rank held Haemonetics as of Q2 2024.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.